Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Structure Therapeutics Inc.GPCR · Entity 1222 | CHIEF MEDICAL OFFICER | September 18, 2026 | September 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Structure Therapeutics Inc.
Report date September 18, 2026 · Filed September 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 270,252 |
Reported balance
After 2026-09-18 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-09-18 · Tax withholding · Disposed 10,626 · Balance 270,252 F1: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award. F3: Reflects price per share in Ordinary Shares. |
| Ordinary SharesSEC Table I · non-derivative | Direct | 258,228 |
Reported balance
After 2026-09-21 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2026-09-21 · Conversion · Disposed 12,024 · Balance 258,228 F4: 12,024 Ordinary Shares were converted into 4,008 American Depositary Shares as reported in Table II. |
| American Depositary SharesSEC Table II · derivative / convertible security | Direct | 5,165 |
Reported balance
After 2026-09-21 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-09-21 · Conversion · Acquired 4,008 · Balance 5,165 F5: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F4: 12,024 Ordinary Shares were converted into 4,008 American Depositary Shares as reported in Table II. |
| American Depositary SharesSEC Table II · derivative / convertible security | Direct | 1,157 |
Reported balance
After 2026-09-21 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-09-21 · Sale · Disposed 4,008 · Balance 1,157 F5: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F6: The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 30, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.
F2: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award.
F3: Reflects price per share in Ordinary Shares.
F4: 12,024 Ordinary Shares were converted into 4,008 American Depositary Shares as reported in Table II.
F5: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date.
F6: The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 30, 2026.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 21, 2026 Filed Sep 22, 2026 21:59 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | SaleAmerican Depositary Shares · Derivative | 4,008 | $36.15 | $144,872.77 |
DisclosureSEC source: 0002037144-26-000004 · form4-09222026_090944.xml · derivative · entry 4 Coll Crespo Blas · CIK 0002037144 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,157 Underlying: Ordinary Shares · 12,024 shares Expires not disclosed F5 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F6 · kind: The American Depositary Shares were sold pursuant to a Rule 10b5-1 trading plan entered into on March 30, 2026. F5 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F5 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| September 21, 2026 Filed Sep 22, 2026 21:59 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | ConversionAmerican Depositary Shares · Derivative | 4,008 | $0.00 | $0.00 |
DisclosureSEC source: 0002037144-26-000004 · form4-09222026_090944.xml · derivative · entry 3 Coll Crespo Blas · CIK 0002037144 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,165 Underlying: Ordinary Shares · 12,024 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F4 · shares: 12,024 Ordinary Shares were converted into 4,008 American Depositary Shares as reported in Table II. F5 · derivative.exercise_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. F5 · derivative.expiration_date: Each American Depositary Share is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The American Depositary Shares have no expiration date. Read SEC document |
| September 21, 2026 Filed Sep 22, 2026 21:59 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | ConversionOrdinary Shares | 12,024 | $0.00 | $0.00 |
DisclosureSEC source: 0002037144-26-000004 · form4-09222026_090944.xml · nonDerivative · entry 2 Coll Crespo Blas · CIK 0002037144 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 258,228 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · shares: 12,024 Ordinary Shares were converted into 4,008 American Depositary Shares as reported in Table II. Read SEC document |
| September 18, 2026 Filed Sep 22, 2026 21:59 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Tax withholdingOrdinary Shares | 10,626 | $11.67 | $124,005.42 |
DisclosureSEC source: 0002037144-26-000004 · form4-09222026_090944.xml · nonDerivative · entry 1 Coll Crespo Blas · CIK 0002037144 · CHIEF MEDICAL OFFICER 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 270,252 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award. F3 · price: Reflects price per share in Ordinary Shares. Read SEC document |
| March 19, 2026 Filed Mar 23, 2026 16:30 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantEmployee Stock Option (right to buy) · Derivative | 93,984 | $0.00 Strike: $16.82 | $0.00 |
DisclosureSEC source: 0002037144-26-000003 · form4-03232026_040308.xml · derivative · entry 2 Coll Crespo Blas · CIK 0002037144 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,984 Underlying: Ordinary Shares · 93,984 shares Expires 2036-03-18 F3 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. F4 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| March 19, 2026 Filed Mar 23, 2026 16:30 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantOrdinary Shares | 75,897 | $0.00 | $0.00 |
DisclosureSEC source: 0002037144-26-000003 · form4-03232026_040308.xml · nonDerivative · entry 1 Coll Crespo Blas · CIK 0002037144 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 280,878 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2026, subject to Reporting Person's continued service on such dates. Read SEC document |
| March 03, 2026 Filed Mar 5, 2026 18:20 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Tax withholdingOrdinary Shares | 11,826 | $20.99 | $248,227.74 |
DisclosureSEC source: 0002037144-26-000002 · form4-03052026_060312.xml · nonDerivative · entry 1 Coll Crespo Blas · CIK 0002037144 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 204,981 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award. Read SEC document |
| September 18, 2025 Filed Sep 22, 2025 21:25 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Tax withholdingOrdinary Shares | 8,106 | $7.74 | $62,767.19 |
DisclosureSEC source: 0002037144-25-000003 · form4-09222025_090901.xml · nonDerivative · entry 1 Coll Crespo Blas · CIK 0002037144 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 216,807 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 17:15 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Tax withholdingOrdinary Shares | 1,434 | $6.84 | $9,803.68 |
DisclosureSEC source: 0001415889-25-019354 · form4-07032025_050709.xml · nonDerivative · entry 3 Coll Crespo Blas · CIK 0002037144 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,913 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award. Read SEC document |
| July 01, 2025 Filed Jul 3, 2025 17:15 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantOrdinary Shares | 7,992 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-019354 · form4-07032025_050709.xml · nonDerivative · entry 2 Coll Crespo Blas · CIK 0002037144 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226,347 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F3 · kind: On March 15, 2024, the reporting person was granted performance-vesting restricted share units ("PSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer, which vest upon satisfaction of certain performance criteria. Certain of the performance criteria was determined to have been met effective July 1, 2025. The shares subject to the PSUs vest as follows: 50% of the shares vested on July 1, 2025 and the remainder will vest on January 1, 2027 subject to the reporting person's Continuous Service (as defined in the Structure Therapeutics Inc. 2023 Equity Incentive Plan) through such vesting date. Read SEC document |
| May 21, 2025 Filed Jul 3, 2025 17:15 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantAmerican Depositary Shares · Derivative | 429 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-019354 · form4-07032025_050709.xml · derivative · entry 4 Coll Crespo Blas · CIK 0002037144 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,157 Underlying: Ordinary Shares · 1,287 shares Expires not disclosed F4 · derivative.exercise_price: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F5 · kind: Voluntary reporting of the acquisition of 429 ADSs by the Reporting Person on May 21, 2025 pursuant to the Issuer's Employee Share Purchase Plan. F4 · derivative.exercise_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F4 · derivative.expiration_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 20:45 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantEmployee Stock Option (right to buy) · Derivative | 284,241 | $0.00 Strike: $7.02 | $0.00 |
DisclosureSEC source: 0001415889-25-008555 · form4-03182025_080313.xml · derivative · entry 2 Coll Crespo Blas · CIK 0002037144 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 284,241 Underlying: Ordinary Shares · 284,241 shares Expires 2035-03-14 F3 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. F4 · derivative.exercise_date: 1/4th of the shares subject to the option shall vest March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| March 15, 2025 Filed Mar 18, 2025 20:45 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantOrdinary Shares | 116,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008555 · form4-03182025_080313.xml · nonDerivative · entry 1 Coll Crespo Blas · CIK 0002037144 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 219,588 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · kind: Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one Ordinary Share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates. Read SEC document |
| March 01, 2025 Filed Jul 3, 2025 17:15 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | Tax withholdingOrdinary Shares | 1,233 | $7.92 | $9,761.17 |
DisclosureSEC source: 0001415889-25-019354 · form4-07032025_050709.xml · nonDerivative · entry 1 Coll Crespo Blas · CIK 0002037144 · CHIEF MEDICAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 218,355 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · shares: Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a restricted share unit award. Read SEC document |
| November 20, 2024 Filed Mar 18, 2025 20:45 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantAmerican Depositary Shares · Derivative | 363 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-008555 · form4-03182025_080313.xml · derivative · entry 3 Coll Crespo Blas · CIK 0002037144 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 728 Underlying: Ordinary Shares · 1,089 shares Expires not disclosed F5 · derivative.exercise_price: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F6 · kind: Voluntary reporting of the acquisition of 363 ADSs by the Reporting Person on Novembery 20, 2024 pursuant to the Issuer's Employee Share Purchase Plan. F5 · derivative.exercise_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F5 · derivative.expiration_date: Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| September 18, 2024 Filed Sep 20, 2024 17:42 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantShare option (right to buy) · Derivative | 111,000 | $0.00 Strike: $12.75 | $0.00 |
DisclosureSEC source: 0001415889-24-023791 · form4-09202024_090935.xml · derivative · entry 2 Coll Crespo Blas · CIK 0002037144 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,000 Underlying: Ordinary Shares · 111,000 shares Expires 2034-09-17 F3 · derivative.exercise_price: The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs. F4 · derivative.exercise_date: One-fourth of the shares vest on the first anniversary of September 18, 2024, and the remaining shares shall vest in thirty-six (36) equal monthly installments thereafter. F1 · derivative.underlying: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. Read SEC document |
| September 18, 2024 Filed Sep 20, 2024 17:42 UTC | Structure Therapeutics Inc. GPCR · Entity 1222 | GrantOrdinary Shares | 90,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-24-023791 · form4-09202024_090935.xml · nonDerivative · entry 1 Coll Crespo Blas · CIK 0002037144 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 102,600 F1 · security: The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer. F2 · shares: Represents restricted stock unit award granted under the Issuer's 2023 Equity Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.